← Back to Search

Gamification for Hospital Mobility Improvement (Level Up Trial)

N/A
Waitlist Available
Led By Ryan Greysen, MD, MHS, MA
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have an AMPAC (mobility scale) score of greater than or equal to 21 or a Braden mobility sub-scale score of 4.
Admitted to a medicine or cardiology floor in the hospital
Must not have
Does not have daily access to a smartphone compatible with the wearable device and not willing to use a device that the study team can provide
Inpatient AMPAC score of less than 21 or a Braden mobility sub-scale score less than 4 indicating that independent physical activity may not be appropriate for the patient
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average 35 days
Awards & highlights

Summary

This trial will use wearable devices and 2-way texting to monitor patients' physical activity during hospitalization, with the goal of improving patient outcomes.

Who is the study for?
This trial is for hospital patients aged 50 or older with conditions like diabetes, heart disease, or obesity. They must be able to consent, have daily access to a smartphone (or use one provided), and not be in another activity study. Their mobility scores should indicate they can safely do physical activities.
What is being tested?
The study tests if adding game-like elements (gamification) to monitoring devices increases patient movement in the hospital. It compares regular guidance with enhanced gamified feedback using wearables and texting, then tracks post-discharge health care use and function.
What are the potential side effects?
Since this trial involves non-invasive interventions like wearable technology and text messaging rather than medications, side effects are minimal but may include discomfort from wearing the device or potential privacy concerns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can move around well enough on my own.
Select...
I am currently admitted to a hospital's medicine or cardiology department.
Select...
I am 50 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't use a smartphone daily and am not willing to use one provided for the study.
Select...
I may need help with moving around due to my low mobility scores.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average 35 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and average 35 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in mean daily step count during hospitalization
Secondary study objectives
30-day acute care utilization
Change in activities of daily living
Change in difficulty with walking
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gamification InterventionExperimental Treatment1 Intervention
Participants will be recruited during an inpatient stay and given a Fitbit watch that will transmit data to the Way to Health study platform. Intervention patients will receive daily text messages to help them set goals, receive feedback and support on their progress towards daily goals, and receive points for daily goals achieved. Data will continue to be collected for 30 days after discharge.
Group II: ControlActive Control1 Intervention
Participants will be recruited during an inpatient stay and given a Fitbit watch that will transmit data to the Way to Health study platform. Control participants' steps will be passively monitored. Data will continue to be collected for 30 days after discharge.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,012,977 Total Patients Enrolled
5 Trials studying Coronary Artery Disease
270 Patients Enrolled for Coronary Artery Disease
Ryan Greysen, MD, MHS, MAPrincipal InvestigatorUniversity of Pennsylvania
4 Previous Clinical Trials
807 Total Patients Enrolled

Media Library

Gamification Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04300764 — N/A
Coronary Artery Disease Research Study Groups: Control, Gamification Intervention
Coronary Artery Disease Clinical Trial 2023: Gamification Intervention Highlights & Side Effects. Trial Name: NCT04300764 — N/A
Gamification Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04300764 — N/A
Coronary Artery Disease Patient Testimony for trial: Trial Name: NCT04300764 — N/A
~100 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top